KIORA PHARMACEUTICALS INC (KPRX)
Latest KPRX Insider Trades
Melissa Tosca - OfficerTax withholding / forfeiture$2K
Brian M. Strem - OfficerTax withholding / forfeiture$5K- Carmine N. Stengone - Director
About KIORA PHARMACEUTICALS INC (KPRX)
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
- ENCINITAS, CA
- 13
- 2015
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 6 | 165,000 | |
| Tax withholding / forfeiture | 2 | 2,780 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
KPRX Insider Transactions (Form 4)
2017 Form 4 filings on record, the earliest from Apr 1, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Melissa Tosca - Officer | Tax withholding / forfeiture | Common Stock |
Recent KPRX Form 8-K Filings
5KPRX Insider Trading - FAQ
What is the latest insider trade for KPRX?
KIORA PHARMACEUTICALS INC (KPRX) had 8 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for KPRX runs to 17 Form 4 filings, the earliest from 2025-04-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying KPRX stock?
No insider purchases of KPRX were filed in the last 90 days.
How many insiders are selling KPRX stock?
No insider sales of KPRX were filed in the last 90 days.
Where can I see KPRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks KPRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow KPRX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add KPRX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Melissa Tosca view on EDGAR
- - Brian M. Strem view on EDGAR
- - Carmine N. Stengone view on EDGAR
- - Aron Shapiro view on EDGAR
- - Erin Parsons view on EDGAR
- - David Hollander view on EDGAR
- - Lisa Walters-Hoffert view on EDGAR
- - Praveen Tyle view on EDGAR
- - Melissa Tosca view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where KPRX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track KPRX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
